HSBC upgrades Labcorp to buy with $410 target
Alpha Vantage · MarketBeat · · AI-summarised by FinFlash
HSBC upgraded Labcorp (NYSE:LH) from hold to buy with a $410 price target, implying 11.4% upside. The upgrade follows quarterly earnings that beat estimates, with EPS of $4.78 and revenue of $3.81 billion, up 6.9% year over year. Analysts hold a Moderate Buy consensus with an average target of $369.08. The upgrade signals improving sentiment on the diagnostics sector.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.